CORE1: Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).

被引：0

作者：

Rixe, Olivier ^{[1
]}

Castonguay, Vincent ^{[2
]}

Conter, Henry ^{[3
]}

Chalas, Eva ^{[4
]}

Desai, Pratibha

Squillante, Christian ^{[5
]}

MacDonald, Lisa A. ^{[6
]}

Conlon, Rebekah ^{[6
]}

Bramhecha, Yogesh ^{[6
]}

Hirsch, Heather ^{[6
]}

Graff, Jeremy R. ^{[6
]}

Fiset, Stephan ^{[7
]}

机构：

[1] Quantum Santa Fe, Santa Fe, NM USA

[2] Univ Laval, CRCHU Quebec, Quebec City, PQ, Canada

[3] William Osler Hlth Syst, Brampton, ON, Canada

[4] NYU Langone Hosp, Perlmutter Canc Ctr, Mineola, NY USA

[5] Allina Hlth, Minneapolis, MN USA

[6] IMV Inc, Dartmouth, NS, Canada

[7] IMV Inc, Quebec City, PQ, Canada

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT036

引用

页数：2

共 50 条

[41] Impact of Bacillus Calmette-Guerin (BCG) shortage on the management of high risk non-muscle invasive bladder cancer: a single centre study
Huang, D.
Perera, M.
Khan, M.
Lawrentschuk, N.
Newbold, R.
Sengupta, S.
BJU INTERNATIONAL, 2018, 121 : 82 - 83
[42] Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies
Kiselyov, Alex
Bunimovich-Mendrazitsky, Svetlana
Startsev, Vladimir
BBA CLINICAL, 2015, 4 : 27 - 34
[43] Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer
Andrade, Danilo Leite
Moretti, Tomas Bernardo Costa
Neto, Wilmar Azal
Benedetti, Julia
Reis, Leonardo Oliveira
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1471 - 1476
[44] A PHASE II/III TRIAL OF CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-REFRACTORY NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC)
Packiam, Vignesh T.
Campanile, Alexa N.
Barocas, Daniel A.
Chamie, Karim
Davis, Ronald L., III
Kader, A. Karim
Lamm, Donald L.
Yeung, Alex W.
Steinberg, Gary D.
JOURNAL OF UROLOGY, 2016, 195 (04): : E142 - E142
[45] A study of intravesical bacillus Calmette-Guerin (BCG) in combination with ALT-803 in patients with non-muscle invasive bladder cancer.
Rosser, Charles Joel
Chamie, Karim
Rock, Amy
Ferguson, Lydia
Wong, Hing C.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[46] Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
Li, Roger
Sylvester, Richard
Dinney, Colin P.
Kamat, Ashish M.
BLADDER CANCER, 2017, 3 (03) : 147 - 148
[47] Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, in Non-Muscle Invasive Bladder Cancer
Nemunaitis, John
Maslyar, Daniel
McKiernan, James
Meng, Maxwell
Stephenson, Joseph
Arseneau, James
Aimi, Junko
Yeung, Alex
Kazarian, Troy
Burke, James
Lamm, Donald
MOLECULAR THERAPY, 2012, 20 : S210 - S210
[48] Treatment strategies for the Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
Jeong, Seung-hwan
Ku, Ja Hyeon
INVESTIGATIVE AND CLINICAL UROLOGY, 2023, 64 (02) : 103 - 106
[49] Role of immunotherapy in bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
Mukherjee, Neelam
Svatek, Robert S.
Mansour, Ahmed M.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (03) : 103 - 108
[50] Updated Interim Analysis from Keynote-057: Pembrolizumab Monotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
Krieger, Laurence
de Wit, Ronald
Kulkarni, Girish S.
Uchio, Edward M.
Boormans, Joost L.
Roumiguie, Mathieu
Singer, Eric A.
Bajorin, Dean F.
Kamat, Ashish M.
Grivas, Petros
Seo, Ho Kyung
Nishiyama, Hiroyuki
Konety, Badrinath R.
Nam, Kijoeng
Kapadia, Ekta
Frenkl, Tara L.
Balar, Arjun Vasant
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 52 - 53

← 1 2 3 4 5 →